The Academy of Pharmaceutical Science and Technology, Japan (APSTJ) Annual Meeting is a scientific conference that brings together pharmaceutical researchers, industry professionals and academic experts to share advancements in drug development, formulation science and delivery technologies. It features presentations, symposia and collaborative discussions aimed at advancing innovation and strengthening connections across the pharmaceutical industry.

Date: June 3-5, 2026
Location: Kyoto, Japan
https://www.apstj.jp/en/

JOIN US!

Connect with Catalent at the annual APST Japan Annual Meeting to explore how our advanced drug delivery technologies and development expertise can help accelerate your programs from concept to clinic. Our team is ready to collaborate on tailored solutions that enhance patient outcomes and streamline your path to market.

Complete the form to schedule a meeting with our experts!

SPEAKING ENGAGEMENTS

Speaker: Karunakar Sukuru (Karu), R.Ph., Ph.D., Global Vice President-Pharma Product Development & Head- Scientific Advisory
Date/Time: Thursday, June 4, 2026 at 12:30pm
Title: Enabling Oral Delivery of Complex Therapeutics with Lipid Based Softgel Technologies
Location: Kyoto International Exhibit Hall, Room #4

Oral delivery of PROTACs, peptides and other poorly soluble or permeable molecules remains a significant challenge. Recent advances in lipid-based formulations and softgel technologies help overcome these barriers and improve oral bioavailability. This presentation will highlight examples from marketed products alongside Catalent case studies, and explore how Catalent’s global softgel network across Japan, the U.S., and the EU supports the successful oral delivery of complex therapeutics.

ABOUT CATALENT

Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that Catalent helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. Catalent provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. Catalent tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matter™